24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Immunotherapy Industry, February 2015 Market Reports from Top Publishers

You might be interested in: therapeutics, cancer, medical equipment, drug, cancer drug, cancer immunotherapy, alzheimer's disease, biotherapeutics, cancer centre, cancer therapeutics, lymphoma, arthritis, atherosclerosis, bladder cancer, chemotherapy.


 
1-10 of 47 reports for Immunotherapy

Immunotherapy in Oncology: Drug Pathway Analyzer 2015

Immunotherapy in Oncology: Drug Pathway Analyzer 2015

  • $ 3 675
  • Industry report
  • January 2015
  • by Bioseeker

... Specifications3. Compare - you can overlay any pathways with each other and do a comparative analysisyou can interactively analyze any immunotherapy drug-pathway relationship by using up to four ...

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

Opexa Therapeutics, Inc. (Symbol:OPXA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Which is a personalized t-cell immunotherapy in a phase iib clinical development program for the treatment of secondary progressive multiple sclerosis. The company specializes in flow cytometry ...

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

Bluebird bio, Inc. (BLUE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Indexoct 01, 2013: richard morgan, ph.D. Joins bluebird bio as vice president of immunotherapythis comprehensive swot profile of bluebird bio, inc. Provides you an in-depth strategic analysis ...

Immunotherapy in Oncology Drug Pipeline Update 2015

Immunotherapy in Oncology Drug Pipeline Update 2015

  • $ 3 675
  • Industry report
  • January 2015
  • by Bioseeker

... For mac users the service is only available online- browser application (internet explo, firefox, chrome, safari)- internet access (to access related internet resources) immunotherapy ...

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

Targeting Immune Checkpoints in Cancer Immunotherapy Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

... Targeting immune checkpoints in cancer immunotherapy drug pipeline update 2015 bioseeker's targeting immune checkpoints in cancer immunotherapy: drug pipeline update is the most up to date ...

MediGene AG (Symbol:MDG) SWOT Analysis, Strategy, Revenues and Profits

MediGene AG (Symbol:MDG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • December 2014
  • by Global Data

... Trianta receives bmbf (federal ministry of education and research) grant for tabs immunotherapy as part of the "m4 leading-edge cluster initiative" 43may 15, 2014: medigene significantly improves ...

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

Genitope Corporation (GTOP) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Amplification helps development of personalized active immunotherapies. Genitope help patients who are diagnosed with b-cell malignancies. The company is headquartered in california, the us ...

Oncothyreon Inc. (ONTY) - Financial and Strategic SWOT Analysis Review

Oncothyreon Inc. (ONTY) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Ont-10 and tecemotide constitute to oncothyreon s antigen- specific immunotherapy platform. It also focuses on clinical development and market commercialization of its pipeline programs. The company ...

Dendritic Cell and CAR-T Therapies Market, 2014 - 2024

Dendritic Cell and CAR-T Therapies Market, 2014 - 2024

  • $ 1 899
  • Industry report
  • November 2014
  • by Roots Analysis Private Ltd.

... Firms developing whole cell based immunotherapies. - Competitive landscape and inherent threats to growth in the short and long term. - Development and sales potential based on target consumer ...

Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... And commercialize adjuvanted vaccine and immunotherapy technology in the field of human health. It has strategic alliance with bayer healthcare ag for the use of its technology in the field of animal health. Juvaris ...

About 800 reports for Immunotherapy

Download Unlimited Documents from Trusted Public Sources

Medinet Annual Report 2013

  • January 2013
    171 pages
  • Equity Market  

    Preferred Stock  

    Common Stock  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.